Clinical trial
Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.
NCT00418002 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00418002 |
|---|---|
| Title | Safety and Tolerability of AQW051 in Elderly Healthy Volunteers. |
| Official title | A Randomized, Double-Blind, Ascending Dose, Placebo-Controlled Single Dose Study in Non-Smoking Healthy Elderly Subjects Interleaved With a 2-Week Multiple Once Daily Dose Study to Explore Safety, Tolerability, Pharmacokinetics and Cognitive Effects After Oral Administration of AQW051 |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | AQW051 |
| Enrollment | 72 |
| Start date | May 1, 2006 |
| First posted | Jan 4, 2007 |
| Last update posted | Jun 22, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: